tiprankstipranks
Trending News
More News >
Mankind Pharma Ltd. (IN:MANKIND)
:MANKIND
India Market
Advertisement

Mankind Pharma Ltd. (MANKIND) Financial Statements

Compare
7 Followers

Mankind Pharma Ltd. Financial Overview

Mankind Pharma Ltd.'s market cap is currently ₹1.02T. The company's EPS TTM is ₹10.7; its P/E ratio is 53.29; and it has a dividend yield of 0.04%. Mankind Pharma Ltd. is scheduled to report earnings on July 31, 2025, and the estimated EPS forecast is ₹13.00. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Currency in INR

Mankind Pharma Ltd. Earnings and Revenue History

Mankind Pharma Ltd. Debt to Assets

Mankind Pharma Ltd. Cash Flow

Mankind Pharma Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis